Integrated Quantitative Investments’s Bristol-Myers Squibb BMY Stock Holding History

Integrated Quantitative Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,872	Closed	-$599K	–	403
2026 Q1	$599K	Buy	+9,872	New	+$575K	0.11%	257
2025 Q4	–	Sell	-5,900	Closed	-$266K	–	410
2025 Q3	$266K	Sell	5,900 -4,790	-45%	-$224K	0.08%	282
2025 Q2	$495K	Buy	+10,690	New	+$525K	0.15%	219
2025 Q1	–	Sell	-7,000	Closed	-$396K	–	291
2024 Q4	$396K	Buy	+7,000	New	+$391K	0.2%	149

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Integrated Quantitative Investments's BMY Position: Q2 2026 in Review

Integrated Quantitative Investments sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 9,872 shares — an estimated $599K sold.

Integrated Quantitative Investments first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $599K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Integrated Quantitative Investments reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Integrated Quantitative Investments sold 9,872 Bristol-Myers Squibb shares in Q2 2026, an estimated $599K.
Integrated Quantitative Investments first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
Integrated Quantitative Investments's Bristol-Myers Squibb position peaked at $599K in Q1 2026.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.